NEW

Siemens Healthineers to Acquire Varian

Siemens Healthineers AG and Varian Medical Systems Inc. have entered into an agreement, pursuant to which Siemens Healthineers shall acquire all shares of Varian for $177.50 per share in cash. This corresponds to a purchase price of approximately $16.4 billion....

MTMI Partners with Nautilus Medical Technologies

The Medical Technology Management Institute (MTMI), a division of The College of Health Care Professions, has announced a partnership with Nautilus Medical Technologies, developer of a cloud-based imaging sharing platform used by over a thousand health care providers...

Gillette Children’s Specialty Healthcare is the first U.S. hospital to image patients with EOSedge

EOS imaging, a provider of 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and surgical planning, has announced the first exams performed with EOSedge in the United States, at Gillette Children's Specialty Healthcare’s main campus...

Webinar on FDA’s Regulation of Face Masks and Surgical Masks during the COVID-19 Pandemic

On Tuesday, August 4, 12:00 p.m.-1:00 p.m. ET, the U.S. Food and Drug Administration (FDA) will host a webinar on the FDA’s regulation of face masks and surgical masks during the COVID-19 pandemic. This webinar will expand the scope of the respirator webinar series to...

ASE Elects New President

Judy W. Hung, MD, FASE, is the new president of the American Society of Echocardiography (ASE). She has served on the Board of Directors as Vice President and President-Elect prior to ascending to her one-year presidency.

Dr. Hung will share her vision for the future of ASE on Saturday, August 8, during the opening session of the ASE 2020 Scientific Sessions Virtual Experience. When asked about her upcoming presidency, she said “I see tremendous opportunity for ASE to advance its mission to be the leader of quality, education, innovation, research, and advocacy in the field of cardiovascular ultrasound. ASE is currently well-positioned to adapt to the changing and challenging healthcare environment and to lead innovation in echocardiography through its international reputation, organizational infrastructure, and commitment to quality and research. I have a deep admiration and belief in the goals and mission of the ASE and the dedication of my ASE member colleagues.”

Dr. Hung is Director of the Echocardiography Lab, Division of Cardiology, at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School. She has a special interest in valvular heart disease, coronary artery disease, and optimizing noninvasive cardiac imaging techniques to improve diagnosis and treatment of heart disease. Her research involves understanding mechanisms of valvular heart disease and development of novel therapies to treat valve disease.

For more information, visit https://bit.ly/2NNcL0l.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *